Transaction #12875 · Form 4 · 0000902664-25-005164
EXELIXIS, INC. · Purchase · Common Stock
EXELIXIS, INC. · Transacted November 25, 2025 · Filed November 26, 2025
What does this filing report?
An SEC Form 4 filing for EXELIXIS, INC. records a purchase involving Common Stock on November 25, 2025. The reported quantity was 27,532. The filing date is November 26, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- EXELIXIS, INC.
- Company CIK
- 0000939767
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 27,532
- Reported price
- 43.122
- Reference value
- 1,187,234.904
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 1,553,262
- Ownership description
- See footnote
- SEC acceptance time
- Nov 26, 2025, 4:05 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Caligan Partners LP ↗
Director · See Remarks
CIK 0001727492
- JOHNSON DAVID EDWARD ↗
Director
CIK 0001785557
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- This Form 4 is filed by David Johnson ("Mr. Johnson") and Caligan Partners LP ("Caligan") with respect to the securities held by Caligan Partners Master Fund LP ("Caligan Master Fund"), a Cayman Islands limited partnership, and managed accounts ("Caligan Accounts", together with the Caligan Master Fund, the "Caligan Fund and Accounts") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
- F2
- Includes 9,088 shares of common stock that will be issued to Mr. Johnson upon vesting of restricted stock units. Mr. Johnson is deemed to hold the securities reported herein for the benefit of the Caligan Fund and Accounts, and may, after vesting, if applicable, transfer the securities directly to the Caligan Fund and Accounts.
Remarks
Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Caligan may be deemed to be a director by deputization of the Issuer by virtue of the fact that Mr. Johnson currently serves on the Issuer's board of directors.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.